Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges

Virology. 2006 Sep 30;353(2):324-32. doi: 10.1016/j.virol.2006.05.033. Epub 2006 Jul 3.

Abstract

The Marburg virus (MARV), an African filovirus closely related to the Ebola virus, causes a deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of disease is only supportive, and no vaccines are available to prevent spread of MARV infections. In order to address this need, we have developed and characterized a novel recombinant vaccine that utilizes a single complex adenovirus-vectored vaccine (cAdVax) to overexpress a MARV glycoprotein (GP) fusion protein derived from the Musoke and Ci67 strains of MARV. Vaccination with the cAdVaxM(fus) vaccine led to efficient production of MARV-specific antibodies in both mice and guinea pigs. Significantly, guinea pigs vaccinated with at least 5 x 10(7) pfu of cAdVaxM(fus) vaccine were 100% protected against lethal challenges by the Musoke, Ci67 and Ravn strains of MARV, making it a vaccine with trivalent protective efficacy. Therefore, the cAdVaxM(fus) vaccine serves as a promising vaccine candidate to prevent and contain multi-strain infections by MARV.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / metabolism*
  • Amino Acid Sequence
  • Animals
  • Antibodies, Viral / blood
  • Antigens, Viral / biosynthesis*
  • Antigens, Viral / genetics
  • Cell Line
  • Chlorocebus aethiops
  • Dose-Response Relationship, Immunologic
  • Ebola Vaccines / administration & dosage*
  • Ebola Vaccines / genetics
  • Genetic Therapy / methods
  • Genetic Vectors / metabolism*
  • Guinea Pigs
  • Humans
  • Injections, Intraperitoneal
  • Injections, Subcutaneous
  • Marburg Virus Disease / blood
  • Marburg Virus Disease / immunology
  • Marburg Virus Disease / prevention & control*
  • Marburgvirus / immunology*
  • Mice
  • Molecular Sequence Data
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Sequence Alignment
  • Vaccination*
  • Vaccines, Synthetic / administration & dosage
  • Viral Envelope Proteins / biosynthesis*
  • Viral Envelope Proteins / genetics
  • Viral Fusion Proteins / biosynthesis*
  • Viral Fusion Proteins / genetics

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Ebola Vaccines
  • GP-protein, Marburg virus
  • Recombinant Proteins
  • Vaccines, Synthetic
  • Viral Envelope Proteins
  • Viral Fusion Proteins